NMTC NeuroOne Medical Technologies Corp

$NMTC Today, we published preliminary product revenue results for fiscal Q4 and full-year 2026, reflecting continued commercial growth and a strong finish to the fiscal year. Q4 product revenue is expected to reach approximately $3.8 million, up 38.4% year over year. Full-year product revenue is expected to reach approximately $10.5 million, representing 15.6% growth and landing at the top of our previously announced guidance range of $9.2 million to $10.5 million. Reaching the upper end of that range marks an important execution milestone as we continue working to expand the commercial reach of our neurotechnology portfolio. The fourth-quarter performance also provides a stronger revenue foundation as we begin fiscal 2027. Figures are preliminary and unaudited, and remain subject to year-end accounting and audit procedures. Complete financial results are expected in December 2026.

$NMTC We enter fiscal 2027 with $5.4 million in open purchase orders as of September 30, following a $4.5 million purchase order secured in September—the largest in NeuroOne’s history. Approximately $1 million of the record order shipped in September. Remaining shipments are expected to begin in fiscal Q1 and continue into Q2 2027, subject to manufacturing and delivery schedules. This order provides greater visibility into anticipated product shipments and future revenue opportunities. Across fiscal 2026, product orders increased 24.2% compared with the previous year, adding to the commercial foundation supporting our next phase of execution. Alongside fulfilling these orders, our growth priorities include commercialization of the trigeminal neuralgia system, international market expansion and advancement of our drug delivery platform. These priorities connect our existing commercial business with opportunities to expand the reach and applications of NeuroOne’s technology.

$NMTC Today, we announced an agreement with Dartmouth to support research into neurotransmitter sensing using our sEEG electrodes. Dartmouth received approximately $1 million in NIH funding for the project’s first year. Under our subaward agreement, we will receive approximately $200,000 through April 30, 2027, with additional funds expected during the following two years. The objective is to combine electrical recording with neurochemical sensing, working toward potential use in humans. This agreement places our sEEG technology within a Dartmouth-led, NIH-funded research project alongside the VA Medical Center and Beth Israel Deaconess Medical Center. It adds a new institutional research collaboration to the commercial progress reflected in our preliminary FY2026 results and open purchase orders entering FY2027. We’ll continue sharing updates as this research progresses.

$NMTC delivers preliminary Q4 product revenue up 38.4% and announces a record $4.5 million purchase order.

$NMTC NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

$NMTC what are you doing NueroOne?! Burned up 95% of shareholder value while your ceo continues to say we’re almost to commercialization. Get creative. Work harder and maybe give up your salary until you stop burning so much cash you have to dilute continuously. Even your new biz dev guy is dumping shares. Shows a lot of optimism. End rant. Wish I never came across this turd

$NMTC can’t hold gains. Company reaching with another average pr trying to prop up before announced dilution. Market is pricing this for at least 50% dilution with their ATM program. Hope it recovers to post split prices but seems very far away with today’s action. Would take a 400% move to get back to where it was 🙄

$NMTC $9.4m valuation! Nice job team. Crushing it. Must be pricing for massive dilution to keep ceos salary alive. Always thought this micro operated differently by not carrying debt and not a crazy cash burn rate. What a mistake that thought was. Just announce dilution already so investors can determine where the value should be.

$NMTC Buying more of this stock every day. While everyone cries about low prices, their muppet mouths will be shut when it rips.

$NMTC $GMED $BSX it's called an Easter Egg....hints....tagged Boston Scientific and Globus Medical....who are we in talks with? Top tier

$nmtc advanced discussions for over a year now??? How long has it been this was in a March letter

This scammer trying to manipulate $NMTC cries about people blocking him, then blocks me. Absolute wanker chump. Hence why he lives with his mother trading her money. Pathetic!

$NMTC 1 to 6 reverse stock split last April. How did that work out for $1 stock price compliance?